单细胞基因组学突出显示MYC相关的代谢激活和T型多淋巴细胞白血病进展中的改变细胞相互作用
Linus Wahnschaffe1,2,3,4, Dennis Jungherz1,2,3,5, Tony A Müller1,2,3
1Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), University Hospital Cologne, Cologne, Germany.
Nature communications
|March 10, 2026
概括
型多淋巴细胞白血病 (T-PLL) 可以随意开始. 分子分析显示,随着疾病的进展,T-PLL细胞获得能量并逃脱免疫控制,提供潜在的治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 型多淋巴细胞白血病 (T-PLL) 往往呈现出侵略性,但一个子集表现出惰性阶段.
- 了解T-PLL从惰到活跃阶段的进展的分子驱动因素对于开发向疗法至关重要.
研究的目的:
- 定义与从惰性白血病过渡到活性T型多リン细胞白血病相关的分子变化.
- 通过分析疾病进展过程中的基因组和转录组变化来确定潜在的治疗点.
主要方法:
- 28个未经治疗的T-PLL样本的单细胞RNA测序 (scRNA-seq).
- 配对的惰性和活性T-PLL样本的纵向全基因组测序 (WGS).
- 对基因表达特征的分析,重点关注MYC标和T细胞受体信号传递.
主要成果:
- 在T-PLL进展过程中确定了患者特异性和常见的全球基因表达改变.
- 观察到MYC目标基因的上调和活性T-PLL中增强的能量代谢.
- 发现T细胞受体信号基因的降低调节,并减少了与高级T-PLL中非白血病细胞的相互作用.
结论:
- T-PLL进展涉及获得的细胞自主性,包括增强的能量代谢和逃避监管生存信号.
- 基因组和转录组洞察力揭示了T-PLL.瘤进化的共享机制.
- 鉴定的分子变化代表了针对T-PLL的新型治疗策略的潜在目标.
相关概念视频
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Induced Pluripotent Stem Cells
5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.8K


